glutathione and glycine Induction of biosynthesis by glycine-based treatment mitigates atherosclerosis glycine glutathione transferase The role

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties [1] [2]

Gastrointestinal discomfort is transient in most reports, resolving within the first week of administration without dose adjustment

Once alcohol has entered the bloodstream, eating cannot reduce your existing BAC

A recent study demonstrated that MCI patients that progressed to AD displayed an increased distribution of the ApoE 4 allele, a risk factor for sporadic AD, and displayed a significant decrease in the ratio of oxidized to reduced glutathione and vitamin E levels compared to MCI patients that remained at MCI status over time [39]